2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Alberico L. Catapano(University of Milan), José Luis Zamorano(Hospital Universitario Ramón y Cajal), Arno W. Hoes(University Medical Center Utrecht), W. M. Monique Verschuren(University Medical Center Utrecht), Željko Reiner, Guy De Backer(Ghent University), Ian Graham(Ottawa Hospital), David Wood(Valve (United States)), Ulf Landmesser(Deutsches Herzzentrum der Charité), Heinz Drexel(ESCP Business School), Charalambos Vlachopoulos(ESCP Business School), M. John Chapman(Sorbonne Université), Gabriele Riccardi(University of Milan), Catriona Jennings(Ollscoil na Gaillimhe – University of Galway), Olov Wiklund(Translational Therapeutics (United States)), Terje R. Pedersen(University of Oslo), Lâle Tokgözoğlu(Hacettepe University)
Cited by 3,184
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
2016 European Guidelines on cardiovascular disease prevention in clinical practice
|European Heart Journal|2016|6.5k
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
|New England Journal of Medicine|2017|6k